Navigation Links
MediSapiens Gets $ 1 Million for World's First Personalized Cancer Medicine Software
Date:6/1/2010

HELSINKI, June 1, 2010 /PRNewswire/ -- MediSapiens, world's first software company for personalized cancer medicine in oncology clinics and drug development, completed $ 1 million (EUR 0.8 million) seed round investment from Veraventure, ETFIII advised by Eqvitec Partners, VTT Ventures and Lifeline Ventures.

MediSapiens is based on scientific research at the VTT Technical Research Centre of Finland and its collaborators. MediSapiens hosts world's largest unified gene expression database of human tissues and diseases. This enables scientists to understand the role of human genes in health and disease - to be applied in helping oncologists in choosing optimal treatments and biopharmaceutical companies in developing next generation personalized medicines.

"The latest research - such as The Cancer Genome Atlas funded by the NIH - demonstrates that every patient's cancer is a complex, unique combination of genetic mutations and abnormally expressed genes. The MediSapiens software gives personalized and clinically applicable insight into each patient's cancer," says Tommi Pisto, CEO and Co-founder of MediSapiens.

"Making use of the data produced by the global scientific community provides a new and significant opportunity to understand cancer. Oncologists can benefit when these reference datasets are used to interpret molecular profiling results for individual patients," comments Professor Olli Kallioniemi, MediSapiens board member and director of the Institute for Molecular Medicine Finland (FIMM).

About MediSapiens

MediSapiens, the world's first software company for personalized cancer medicine in oncology clinics and new drug development, hosts world's largest unified gene expression database. With the data online, oncologists have access to evaluate individual patient's genetic signature for the optimized treatment strategy, and scientists understand how genes work across all human tissues. Company's bioinformatics science and peer-reviewed data is based on the research since 2005 by VTT Technical Research Centre of Finland and its collaborators. Visit http://www.medisapiens.fi for more information.

About Veraventure

Veraventure, with assets under management exceeding EUR 100m, is one of the largest early stage funds in Nordic countries. Veraventure makes direct investments in early-stage research, development and innovation intensive enterprises. It also acts as the hub for early-stage venture capital and angel investors as it manages national business angel network with over 100 registered angel investors. Visit http://www.veraventure.fi/company for more information.

About Eqvitec

Eqvitec Partners is one of the largest technology oriented private equity firms in Northern Europe. The company was founded in 1997 and employs 10 investment professionals in Helsinki and Stockholm. Eqvitec Partners currently advises three funds with a total capital base of over EUR 300 million. The funds invest in technology companies in the expansion stage. At the moment the funds have investments in 30 companies and have carried out over 40 exits. Visit http://www.eqvitec.com for more information.

About VTT Ventures

VTT Ventures Ltd is a development company that generates and develops spin-offs based on VTT's technology. We work closely with more than 2,500 VTT researchers and scientists to find the most valuable new technologies to commercialize. Through us, entrepreneurs have access to innovative ideas and know-how of more than 300 patent families. This is the bases for the dealflow that enables us to create growth companies with global potential. Visit http://www.vttventures.fi for more information.

About Lifeline Ventures

Lifeline Ventures, a venture accelerator and early-stage investment fund, co-creates growth companies in health and technology. Being entrepreneurs, we are active team members for an early-stage venture for 12-24 months. Visit http://www.lifelineventures.com for more information.

    Media contact:

    Timo Ahopelto
    VP Strategy
    MediSapiens
    Email: timo.ahopelto@medisapiens.fi
    Telephone: +358-400-569-628


'/>"/>
SOURCE MediSapiens Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alexza Secures $25 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
2. Phreesia to Accelerate Growth with $16 Million Investment Led by Ascension Health Ventures
3. Karmanos Cancer Institutes Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool
4. Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits
5. Ortho-McNeil Pharmaceutical, LLC Pleads Guilty to Illegal Promotion of Topamax and is Sentenced to Criminal Fine of $6.14 Million
6. AstraZeneca Donates $1 Million for Christiana Care Health Systems Wilmington Hospital Project
7. Winner Medical Group Inc. Announces Exercise of Over-Allotment Option Bringing Aggregate Net Proceeds of the Public Offering to $8.8 Million
8. Breathe Technologies Secures $23 Million in Series C Financing
9. ThromboGenics and BioInvent to Receive EUR10 Million Milestone as Partner Roche Begins New Clinical Study with TB-403
10. Curexo Technology Corporation Raises $13.2 Million
11. Alexza Executes $15 million Working Capital Loan with Hercules Technology Growth Capital, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), ... partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry technology ... leading mobile spirometry platform and Novartis, commitment to address the ... ... ...
(Date:9/6/2017)... --  PDI , a leader in infection prevention products ... session focused on the role of chlorhexidine gluconate (CHG) ... 2017 Annual Scientific Meeting of the Association for Vascular ... Phoenix Convention Center in ... also feature PDI,s Prevantics® Device Swab as ...
(Date:9/5/2017)... , Sept. 5, 2017  Getinge, a ... created a vibrant charitable donation program -- "Color ... support congenital heart defect research by The Children,s ... and the general public are encouraged to download ... submit the completed artwork to the gallery on ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... As ... the company recently unveiled a redesigned website. The new site – still located ... building owners, architects, contractors and other industry users that Garland serves. , After ...
(Date:9/20/2017)... ... 20, 2017 , ... The Honey Pot Company is thrilled ... is to ignite conversation via social media and word-of-mouth regarding vaginal health, human ... September “Humans with Vaginas” month, releasing a video celebrating the power of strong ...
(Date:9/20/2017)... Eugene, OR (PRWEB) , ... September 20, 2017 , ... ... OSHA 10- and 30-Hour and HAZWOPER 8-, 24- and 40-Hour courses from now until ... , In addition to offering these discounted prices to all businesses and government ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Finn Mouseson”: follows the exciting story of a ... This mouse sets out on a journey that will show that friends are to ... of newly published author and illustrator, Melody Gersonde-Mickelson, who has earned a bachelor’s degree ...
(Date:9/20/2017)... ... ... to Moorwick”: the adventures of a young Scottish girl yearning to see the world. ... mother of five who used her time waiting for children to finish their extracurricular activities ... It was a way to give some meaning to the hours I waited for ...
Breaking Medicine News(10 mins):